Obesity management: a foundational cardiovascular health priority

1

Obesity is a chronic disease that significantly contributes to the onset and progression of cardiovascular disease (CVD).
2

Recent clinical trials have shown that GLP-1 receptor agonists like semaglutide can reduce cardiovascular events in individuals with obesity and CVD.
3

Effective obesity management is essential for comprehensive CVD risk reduction and can improve multiple health outcomes beyond cardiovascular health.
4

Healthcare systems should prioritize upstream strategies for obesity management to prevent costly complications and improve population-level cardiovascular health.
5

Clinicians must adopt a broader understanding of obesity as a chronic disease and implement individualized approaches to diagnosis and treatment.

European Journal Of Preventive Cardiology

by John W Ostrominski, Jorge Plutzky, Naveed Sattar, Muthiah Vaduganathan, Vanita R Aroda
February 6, 2025

1